SCHEMBL31079040

SCHEMBL31079040

CCOC(=O)C(O)(CC)c1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
MAOA P21397 1/20 0.50
PPIB P23284 1/20 0.42
PPIA P62937 1/20 0.42
PPID Q08752 1/20 0.42
PPIG Q13427 1/20 0.42
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
MAPT P10636 3/20 0.40
TSHR P16473 3/20 0.40
ALDH1A1 P00352 4/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PRKCZ Q05513 1/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26115378 0.89 LMNA (0.49) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL22838048 0.85 LMNA (0.51) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL31078901 0.84 LMNA (0.45) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL10745657 0.84 PIN1 (0.53) CYP3A4MAPTTSHRALDH1A1SMN1; SMN2
SCHEMBL3860904 0.82 ALDH1A1 (0.51) LMNACYP1A2CYP3A4MAPTTSHR
SCHEMBL18053924 0.81 CYP1A2 (0.51) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL940605 0.81 LMNA (0.55) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL10815802 0.81 POLB (0.54) LMNACYP1A2CYP3A4MAOAMAPT
SCHEMBL665559 0.79 CYP1A2 (0.53) LMNACYP1A2CYP3A4MAOAPPIB
SCHEMBL397134 0.79 CYP1A2 (0.53) LMNACYP1A2CYP3A4MAOAPPIB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651872-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-11-26 EP disclosed
WO-2024155601-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-07-25 WO disclosed